| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 40.499 | 45.566 | 55.043 | 47.672 | 60.292 | 46.185 | 56.242 | 54.407 | 61.491 | 61.657 |
| Total Income - EUR | 40.501 | 45.688 | 55.061 | 47.775 | 60.362 | 46.198 | 56.253 | 54.411 | 61.492 | 61.658 |
| Total Expenses - EUR | 37.800 | 23.042 | 20.812 | 22.748 | 23.035 | 19.070 | 20.870 | 23.978 | 26.319 | 23.947 |
| Gross Profit/Loss - EUR | 2.701 | 22.647 | 34.250 | 25.027 | 37.327 | 27.128 | 35.384 | 30.433 | 35.173 | 37.710 |
| Net Profit/Loss - EUR | 1.485 | 21.733 | 33.699 | 24.549 | 36.754 | 26.700 | 34.833 | 29.971 | 34.571 | 35.990 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Enduromedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.825 | 1.428 | 1.032 | 661 | 345 | 77 | 0 | 0 | 13 | 342 |
| Current Assets | 2.945 | 24.652 | 34.451 | 26.546 | 39.861 | 27.739 | 35.699 | 38.280 | 35.658 | 36.888 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 160 | 275 | 361 | 830 | 421 | 436 | 21.590 | 23.007 | 17.621 | 27.955 |
| Cash | 2.785 | 24.377 | 34.090 | 25.716 | 39.440 | 27.302 | 14.109 | 15.273 | 18.038 | 8.933 |
| Shareholders Funds | 3.256 | 24.955 | 33.868 | 24.627 | 37.671 | 26.754 | 34.885 | 30.046 | 34.634 | 36.054 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.514 | 1.124 | 1.615 | 2.580 | 2.536 | 1.062 | 814 | 8.234 | 1.037 | 1.176 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Enduromedica Srl